JP2022518526A5 - - Google Patents

Info

Publication number
JP2022518526A5
JP2022518526A5 JP2021543144A JP2021543144A JP2022518526A5 JP 2022518526 A5 JP2022518526 A5 JP 2022518526A5 JP 2021543144 A JP2021543144 A JP 2021543144A JP 2021543144 A JP2021543144 A JP 2021543144A JP 2022518526 A5 JP2022518526 A5 JP 2022518526A5
Authority
JP
Japan
Prior art keywords
substituted
compounds
alkyl
phenyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021543144A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022518526A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/051836 external-priority patent/WO2020152361A1/en
Publication of JP2022518526A publication Critical patent/JP2022518526A/ja
Publication of JP2022518526A5 publication Critical patent/JP2022518526A5/ja
Pending legal-status Critical Current

Links

JP2021543144A 2019-01-25 2020-01-24 カルバメート誘導体およびその使用 Pending JP2022518526A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962796724P 2019-01-25 2019-01-25
US62/796,724 2019-01-25
PCT/EP2020/051836 WO2020152361A1 (en) 2019-01-25 2020-01-24 Carbamate derivatives and uses thereof

Publications (2)

Publication Number Publication Date
JP2022518526A JP2022518526A (ja) 2022-03-15
JP2022518526A5 true JP2022518526A5 (cg-RX-API-DMAC7.html) 2023-01-31

Family

ID=69375331

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021543144A Pending JP2022518526A (ja) 2019-01-25 2020-01-24 カルバメート誘導体およびその使用

Country Status (13)

Country Link
US (1) US20220098159A1 (cg-RX-API-DMAC7.html)
EP (1) EP3914351A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022518526A (cg-RX-API-DMAC7.html)
KR (1) KR20210131329A (cg-RX-API-DMAC7.html)
CN (1) CN113660983A (cg-RX-API-DMAC7.html)
AU (1) AU2020211361A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021014389A2 (cg-RX-API-DMAC7.html)
CA (1) CA3126495A1 (cg-RX-API-DMAC7.html)
EA (1) EA202192057A1 (cg-RX-API-DMAC7.html)
IL (1) IL284843A (cg-RX-API-DMAC7.html)
MX (1) MX2021008930A (cg-RX-API-DMAC7.html)
SG (1) SG11202107653RA (cg-RX-API-DMAC7.html)
WO (1) WO2020152361A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016057931A1 (en) 2014-10-10 2016-04-14 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
GB201712282D0 (en) 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
NO921449L (no) * 1991-04-17 1992-10-19 American Home Prod Karbamater av rapamycin
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
AU8996698A (en) * 1997-09-10 1999-03-29 Ono Pharmaceutical Co. Ltd. Peroxisome proliferator-activated receptor controllers
US20020002200A1 (en) * 2000-02-04 2002-01-03 Bishwagit Nag Novel diphenylethylene compounds
DE10063008A1 (de) * 2000-12-16 2002-06-20 Merck Patent Gmbh Carbonsäureamidderivate
JP6929792B2 (ja) * 2015-02-16 2021-09-01 ザ ユニバーシティ オブ クィーンズランド スルホニル尿素及び関連化合物並びにその使用
WO2017035413A2 (en) * 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Carbamate, ester, and ketone compounds for treatment of immune and inflammatory disorders
BR112018016671A2 (pt) * 2016-02-16 2018-12-26 The University Of Queensland sulfonilureias e compostos relacionados e uso do mesmo
MX2019008626A (es) * 2017-01-20 2019-09-19 Pfizer Derivados de 1,1,1-trifluoro-3-hidroxipropan-2-ilcarbamato como inhibidores de monoacilglicerol lipasa (magl).
GB2561540A (en) * 2017-03-13 2018-10-24 Nodthera Ltd Chemical compounds
EP3634951B8 (en) * 2017-06-09 2024-08-21 Zydus Lifesciences Limited Novel substituted sulfoximine compounds
GB201712282D0 (en) 2017-07-31 2017-09-13 Nodthera Ltd Selective inhibitors of NLRP3 inflammasome

Similar Documents

Publication Publication Date Title
JP7738910B2 (ja) 置換ピリダジン化合物
CN115066418B (zh) 具有抗炎性质的羧基衍生物
JP7301840B2 (ja) Lpaアンタゴニストとしてのイソキサゾールn結合カルバモイルシクロヘキシル酸
JP6987859B2 (ja) Magl阻害剤
JP2025011095A (ja) パンテテイン誘導体及びその使用
EA036637B1 (ru) Гетероциклические спиросоединения, ингибирующие моноацилглицерин-липазу
JP2020529405A5 (cg-RX-API-DMAC7.html)
JP2022536160A5 (cg-RX-API-DMAC7.html)
TW202227389A (zh) 新穎化合物
US8124778B2 (en) Tricyclic inhibitors of fatty acid amide hydrolase
RS62164B1 (sr) Sulfoniluree i srodna jedinjenja i njihova upotreba
WO2000075113A1 (en) Novel heterocyclic carboxamide derivatives
KR20190077544A (ko) Magl 억제제
JP2023540733A5 (cg-RX-API-DMAC7.html)
JP2010522710A (ja) P2x7調節因子としてのオキサゾリジンおよびモルホリンカルボキサミド誘導体
JP2012524743A (ja) Hsp90阻害剤としてのレゾルシノール誘導体
JP2014523400A (ja) 芳香族アミド類およびそれらの使用
JP2024513227A5 (cg-RX-API-DMAC7.html)
JP2022535956A5 (cg-RX-API-DMAC7.html)
WO2017188357A1 (ja) 置換ジヒドロピロロピラゾール化合物および他の乾癬治療薬が組み合わせて投与される医薬組成物
WO2020100944A1 (ja) ジヒドロピロロピラゾール誘導体
JP7682813B2 (ja) スルホニル尿素誘導体及びその使用
JP2022522890A5 (cg-RX-API-DMAC7.html)
JPWO2006137465A1 (ja) 含窒素複素環誘導体
JP2022535955A5 (cg-RX-API-DMAC7.html)